In addition to these comparisons, we performed analysis of 14 CpG loci within the HLA-DRB1 region which had previously been shown to be differentially methylated in MS patients recruited in Scandinavia and Germany (Kular et al., 2018). This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.